Initial platelet activity may predict efficacy after chronic oral glycoprotein IIb/IIIa blockade: should we still consider uniform treatment regimens?
Gurbel
P A
PA
McKenzie
M E
ME
Serebruany
V L
VL
D000284:Administration, Oral; D015415:Biomarkers / Q000097:blood; D003327:Coronary Disease / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D015539:Platelet Activation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000592:standards; D010979:Platelet Function Tests; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D011379:Prognosis; D013810:Therapeutic Equivalency; D016896:Treatment Outcome
D015415:Biomarkers; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex